SC 13G Filing

Company

Alaunos Therapeutics, Inc.

Filed

December 14, 2009

Accession Number

0000930413-09-006196

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →